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of automatic (AU) and manual (MA) generated H&N VMAT 
plans created for clinical use. 
 
Material and Methods: All patients (n=30) referred to 
curative H&N radiotherapy in August and September 2015 
were planned with a MA and AU VMAT plan in Pinnacle 
version 9.10. Half of the tumours were located in the pharynx 
(15) and the rest were mixed between larynx (4), oral cavity 
(3), salivary glands (2), thyroid gland and unknown primary 
(4). The plans followed national guidelines, and planning 
techniques were blinded before clinical evaluation of senior 
oncologists. The MA plans were optimized according to 
standard clinical practice. The AU plans were created by the 
Autoplan software available in the Pinnacle planning system. 
After AU optimisation, slight manual fine-tuning of the plans 
was performed. To supplement the clinical evaluation the 
operator time for the dosimetrist was recorded along with 
DVH parameters and the global detector pass rate (3% and 
3mm) of the delivered plans on an ArcCheck phantom. All 
statistical analyses were performed with a paired Wilcoxon-
signed rank test. 
 
Results: In 29/30 plans, the AU plan was chosen for clinical 
application (p<0.001). In terms of DVH parameters similar 
target coverage was obtained between the two planning 
methods. As seen in the table, mean OAR doses were 
significantly reduced in the AU plans for all organs. The mean 
reduction ranged from 0.5 Gy for the entire patient to 6.5 Gy 
for the contralateral submandibular gland. Differences in DVH 
showed significant AU superiority in the dose range 10 Gy to 
45 Gy for all organs (Mean DVH example shown in figure). The 
only manual plan selected for clinical use was a thyroid 
cancer plan involving level VII lymph nodes and therefore 
included a large volume of the lung, which had a lower lung 
dose in the manual plan. The AU plans were more modulated 
as illustrated by the increase in MUs, which might cause the 
reduced, but still clinically acceptable, pass rate of 97.7% in 
ArcCheck measurements. The increased beam-on time of 4 
sec is clinically unimportant. Mean operator time spent on MA 
plans was more than twice that of AU plans. The target 
homogeneity, conformity and dose fall off were all superior 
in the AU plans. 
 
 
 
 
Conclusion: All AU and MA plans were of acceptable clinical 
quality, however, AU plans resulted in reduced doses to all 
OAR and required less operator time in the planning process. 
AU plans were almost consistently preferred by senior head 
and neck cancer specialists. The dosimetric superiority of the 
AU plans was evident.  
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Purpose or Objective: RapidPlan (Varian Medical Systems) is 
a knowledge-based planning solution based on a model 
derived from a library of previous treatment plans. The 
model utilizes the geometric features and associated 
dosimetry of these plans to predict a range of achievable 
dose volume histograms (DVHs) for each organ at risk (OAR) 
of a new patient. RapidPlan (RP) drives the VMAT or IMRT 
optimization process by placing a line of optimization 
objectives along the lower boundary of the DVH prediction 
range. Planning inconsistencies may lead to sub-optimal plans 
in the model, which can be identified as dosimetric outliers. 
Outlier cleaning is advised, however this is time consuming 
and often subjective. We examined the effect of model 
cleaning and increasing numbers of dosimetric outliers in a 
model library, on RP plan quality. 
 
Material and Methods: 70 head and neck cancer treatment 
plans (planned consistently using the same departmental 
objective priorities) were used to populate uncleaned 
ModelUC. Statistical metrics provided by RP were used to 
identify geometric/dosimetric outliers in ModelUC which 
were then visually assessed and, if appropriate, removed to 
create cleaned ModelC. The last 5-40 patients (increments of 
5) of ModelC were then re-planned with no attempt to spare 
the salivary glands, and afterward re-introduced to ModelC, 
creating Model5-40. All models were used to create plans for 
a 10 patient evaluation group. Although RP can generate OAR 
objective priorities, for this study, the same standard 
priorities were used as for the plans in ModelUC. Plans were 
compared on the basis of generated prediction ranges, 
boost/elective target volume homogeneity index (HIB/HIE), 
mean dose to the oral cavity (OC) and to composite 
structures comprising the salivary glands (compsal) and 
swallowing structures (compswal). 
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Results: On average, outlier cleaning (ModelUC vs ModelC) 
had minimal impact on HIB/HIE and OAR sparing, although in 
1/10 patients, outlier removal resulted in substantial 
deteriorations to the sparing of two swallowing OAR (>10Gy 
increase). Adding 5/10 outliers to the model marginally 
improved average compsal while increasing the number of 
outliers to 40 led to a 3.9Gy increase in compsal (Table). The 
increase in OAR dose, even with 40 outlier plans added to the 
model, was modest compared to the average increase of 
14.9Gy in compsal, in the outlier plans themselves. This is 
due to the placement of optimization objectives along the 
lower boundary of the DVH prediction range, which 
progressively widened with the addition of outliers. 
 
 
 
Conclusion: This study reveals that extensive outlier cleaning 
from this large model comprising 70 consistently made plans 
had limited impact on the performance of RP. Furthermore, 
the replacement of >20 plans with those in which the salivary 
glands were not spared only modestly deteriorated RP 
performance. In summary, RP demonstrated robustness for 
moderate proportions of salivary gland dosimetric outliers. 
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Purpose or Objective: We examined the feasibility of 
reducing PTV margin when using a simultaneous integrated 
boost (SIB) of pathological lymph nodes in locally advanced 
cervical cancer. Additionally the clinical performance of a 
coverage probability (CovP) planning strategy was 
investigated.  
 
Material and Methods: 25 previously treated patients with 
regional lymph node metastases were included. All patients 
were treated with whole pelvic EBRT (45 Gy/25 fx) using 
IMRT or VMAT. Nodal GTV contouring was based on MRI in 
supine treatment position. A CTV-N was constructed based on 
the combined (fused) nodal GTV-N contoured on MRI and PET-
CT. Treatment planning was performed in Eclipse with three 
margin strategies for the SIB: 1) 10 mm GTV-PTV margin 
(ICRU PTV10mm plan), 2) 5 mm CTV-PTV (ICRU PTV5mm plan) 
and 3) 5 mm CTV-PTV margin using CovP (CovP plan). 
Constraints for the ICRU plans (1+2): PTV coverage of 95-107% 
of prescribed dose. Running a number of CovP plans in the 
research dose planning software Hyperion developed dose 
constraints for CovP planning in Eclipse. CovP dose 
constraints: PTV5mm D98 >90%, CTV D98 > 100% and a soft 
constraint of CTV D50 > 101.5% of prescribed dose (Figure 1). 
Dose prescription for SIB was 55 Gy/25 fx in the true pelvis 
and 57.5 Gy/25 fx above true pelvis. Daily image-guidance 
with cone beam CT (CBCT) and couch correction based on 
bony fusion was used systematically. GTV-N was contoured on 
every second or third CBCT scan and the contour transferred 
to the planning CT. The accumulated dose for each node was 
determined in terms of D98 and Dmax. Finally, the volumes 
of body, bones and bowel receiving >50 Gy (V50) were 
calculated directly from organs at risk (OAR) contours on the 
planning CT. 
 
 
Results: In total 47 lymph nodes were boosted of which 41 
(87%) were visible on CBCT. Median number of nodes per 
patient was 2 (range 1-4). Median GTV D98 and Dmax (%) are 
listed in Table 1. All nodes treated with ICRU plans had a D98 
above 98% and no difference was found between the ICRU 
plans with regard to target coverage. For CovP the D98 was 
significantly lower but Dmax significantly higher when 
compared to the two ICRU plans. Only one node positioned in 
the true pelvis had a D98 below 95% using CovP. In this 
patient, bladder filling varied during EBRT, which resulted in 
large shifts of GTV-N. V50 of body, bones and bowel were 
significantly lower (p<0.001) with the 5mm margin strategy. 
A further significant reduction was seen with the use of CovP 
(p<0.001). 
 
 
Conclusion: Pathological nodes are visible on CBCT in the 
majority of patients with locally advanced cervical cancer. 
Sequential analysis of CBCT taken during EBRT shows that 
nodal boosting by use of SIB and CovP is clinically feasible 
providing an increased central dose in the nodes, full target 
coverage and a significant reduction in near by OAR volumes 
treated to high doses. CovP based SIB using the above 
planning aims are now standard at our institution for nodal 
boosting and will be implemented in the forthcoming 
Embrace II study. 
 
 
 
 
